| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALKS | Alkermes plc. | EVP R&D, Chief Medical Officer | $2.12M | -$18.3M | -89.6% | Nov 3, 2025 |
| ALBO | ALBIREO PHARMA, INC. | Director | $460K | Mar 2, 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|